Physicians' Life

Top Story

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process
November 16, 2017

WASHINGTON — When diagnosed with Hodgkin lymphoma at the age of 33 years, FDA Commissioner Scott Gottlieb, MD, was told he had a 90% chance of survival.

“Ninety percent doesn’t sound so good if it’s you,” Gottlieb, now 44, told HemOnc Today following a keynote presentation at the Friends of Cancer Research Annual Meeting. “So, to me, that 10% sounded pretty grim.”

Stephen M. Ansell, MD, PhD: Translational scientist at heart

January 18, 2017
Stephen M. Ansell, MD, PhD, is professor of medicine at Mayo Clinic in Rochester, Minnesota. He is chair of the Mayo Clinic Lymphoma Group and chair of the scientific…

David H. Ilson, MD, PhD: International traveler and art history enthusiast

December 22, 2016
David H. Ilson, MD, PhD, is a medical oncologist at Memorial Sloan Kettering Cancer Center and a HemOnc Today Editorial Board member. His clinical interests and…

North American outbound medical tourism expected to exceed $15 billion by 2017

November 29, 2016
Future Marketing Insights published a report stating the growth of the North American outbound medical tourism services market is expected to reach $15.53 billion by the…
More Headlines »

Ace the Case: A 48-Year-Old Female Diagnosed With Polycythemia Vera (PV) 7 Years Ago

There is no commercial support for this activity.

This CME case study will discuss the treatment of polycythemia rubra vera.
More »

Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use

September 22, 2017
More »
Resource Centers


Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »